PTGS2 and myeloid sarcoma: Under the conditions of MS, elevated levels of reactive oxygen species (ROS) (together with pro-inflammatory cytokines and certain mediators involved in inflammation status, such as NF-κB and cyclooxygenase-2 (COX-2)) are known to affect cell apoptosis, proliferation, and invasion.